BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38655290)

  • 1. AURKA promotes renal cell carcinoma progression via regulation of CCNB1 transcription.
    Wen J; Wang X; Yang G; Zheng J
    Heliyon; 2024 Apr; 10(8):e27959. PubMed ID: 38655290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZNF655 Promotes the Progression of Glioma Through Transcriptional Regulation of AURKA.
    Chen X; Liu C; Zhang Z; Wang M; Guo S; Li T; Sun H; Zhang P
    Front Oncol; 2022; 12():770013. PubMed ID: 35280721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress.
    Shen Z; Yin L; Zhou H; Ji X; Jiang C; Zhu X; He X
    Cell Oncol (Dordr); 2021 Oct; 44(5):1035-1049. PubMed ID: 34176092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KMT2B promotes the growth of renal cell carcinoma via upregulation of SNHG12 expression and promotion of CEP55 transcription.
    Feng JF; Wang J; Xie G; Wang YD; Li XH; Yang WY; Yang YW; Zhang B
    Cancer Cell Int; 2022 May; 22(1):197. PubMed ID: 35597996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS.
    Dawei H; Honggang D; Qian W
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):83-90. PubMed ID: 30454901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRL-3 Promotes Ubiquitination and Degradation of AURKA and Colorectal Cancer Progression via Dephosphorylation of FZR1.
    Zhang C; Qu L; Lian S; Meng L; Min L; Liu J; Song Q; Shen L; Shou C
    Cancer Res; 2019 Mar; 79(5):928-940. PubMed ID: 30498084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis.
    Cen J; Liang Y; Huang Y; Pan Y; Shu G; Zheng Z; Liao X; Zhou M; Chen D; Fang Y; Chen W; Luo J; Zhang J
    Mol Cancer; 2021 Jan; 20(1):19. PubMed ID: 33468140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA.
    Shen HM; Zhang D; Xiao P; Qu B; Sun YF
    Cancer Gene Ther; 2023 Jul; 30(7):1007-1017. PubMed ID: 36973424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Root extract of Hemsleya amabilis Diels suppresses renal cell carcinoma cell growth through inducing apoptosis and G
    Li K; You G; Jiang K; Wang R; Li W; Meng Y; Fang Y; Chen W; Zhu G; Song J; Wang W; Su H; Hu B; Sun F; Jia Z; Li C; Zhu J
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117014. PubMed ID: 37557938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDCA2 promotes melanoma progression by inhibiting ubiquitin-mediated degradation of Aurora kinase A.
    Sun W; Jin Y; Wei C; Xu Y; Liu W; Zhong J; Zou Z; Lin X; Xiang Y; Chen Y
    Eur J Cancer; 2023 Jul; 188():49-63. PubMed ID: 37196484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m
    Zhang X; Wang F; Wang Z; Yang X; Yu H; Si S; Lu J; Zhou Z; Lu Q; Wang Z; Yang H
    Ann Transl Med; 2020 May; 8(10):646. PubMed ID: 32566583
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Long Q; An X; Chen M; Wang N; Sui S; Li Y; Zhang C; Lee K; Wang X; Tian T; Pan Y; Qiu H; Xie F; Deng W; Zheng F; He L
    Front Oncol; 2020; 10():568015. PubMed ID: 33117697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZNF468 inhibits irradiation-induced G2/M cell cycle arrest and apoptosis by facilitating AURKA transcription in Esophageal Squamous Cell Carcinoma.
    Bai G; Mahati S; Tulahong A; Eli M; Mao R
    Biochem Biophys Res Commun; 2024 Apr; 703():149687. PubMed ID: 38368674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma.
    Wan P; Chen Z; Zhong W; Jiang H; Huang Z; Peng D; He Q; Chen N
    Oncol Rep; 2020 Dec; 44(6):2475-2486. PubMed ID: 33125143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1.
    Chai N; Xie HH; Yin JP; Sa KD; Guo Y; Wang M; Liu J; Zhang XF; Zhang X; Yin H; Nie YZ; Wu KC; Yang AG; Zhang R
    Biochem Biophys Res Commun; 2018 Jun; 500(4):924-929. PubMed ID: 29705704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
    BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.
    Zhu Q; Zhong AL; Hu H; Zhao JJ; Weng DS; Tang Y; Pan QZ; Zhou ZQ; Song MJ; Yang JY; He JY; Liu Y; Li M; Hu WM; Yang CP; Xiang T; Chen MY; Ma G; Guo L; Xia JC
    J Hematol Oncol; 2020 Jan; 13(1):2. PubMed ID: 31900208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Aurora Kinase A by Alisertib Reduces Cell Proliferation and Induces Apoptosis and Autophagy in HuH-6 Human Hepatoblastoma Cells.
    Tan J; Xu W; Lei L; Liu H; Wang H; Cao X; Xu M
    Onco Targets Ther; 2020; 13():3953-3963. PubMed ID: 32440158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p.
    Li J; Huang C; Zou Y; Ye J; Yu J; Gui Y
    Mol Cancer; 2020 Jun; 19(1):103. PubMed ID: 32503552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knocking down the expression of Aurora-A gene inhibits cell proliferation and induces G2/M phase arrest in human small cell lung cancer cells.
    Lu Y; Liu Y; Jiang J; Xi Z; Zhong N; Shi S; Wang J; Wei X
    Oncol Rep; 2014 Jul; 32(1):243-9. PubMed ID: 24841948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.